A Multicenter, Double-Blind, Placebo Controlled, Phase II Study of Aerosolized tgAAVCF for the Treatment of Cystic Fibrosis

Study Summary

The purpose of this study is to confirm the improvement in pulmonary function and cytokine levels observed in the recently completed multidose aerosol study for the treatment of Cystic Fibrosis (CF).

Interventions

Study Locations

Facility	City	State	Country
UAB-Childrens Health System	Birmingham	Alabama	United States
Stanford University Medical Center	Palo Alto	California	United States
UC San Diego	San Diego	California	United States
University of Colorado-The Childrens Hospital	Denver	Colorado	United States
University of Florida	Gainesville	Florida	United States
The Johns Hopkins Hospital	Baltimore	Maryland	United States
Mass General Hospital	Boston	Massachusetts	United States
Childrens Hospital	Boston	Massachusetts	United States
The Minnesota CF Center	Minneapolis	Minnesota	United States
University of Nebraska	Omaha	Nebraska	United States
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	United States

Official Trial Information

View on ClinicalTrials.gov